dopamine transporter

Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson’s Disease With Neuroprotective Potential.

Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson’s Disease with Neuroprotective Potential.

Rambam Maimonides Med J. 2010 Jul; 1(1): e0003
Finberg JP

Rasagiline (Azilect) is a highly selective and potent propargylamine inhibitor of monoamine… Continue reading

Imaging Addiction: D2 Receptors and Dopamine Signaling in the Striatum as Biomarkers for Impulsivity.

Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity.

Neuropharmacology. 2013 Jul 9;
Trifilieff P, Martinez D

Dependence to drugs of abuse is closely associated with impulsivity, or the propensity to choose a lower,… Continue reading

Transdermal Buprenorphine, Opioid Rotation to Sublingual Buprenorphine, and the Avoidance of Precipitated Withdrawal: A Review of the Literature and Demonstration in Three Chronic Pain Patients Treated With Butrans.

Transdermal Buprenorphine, Opioid Rotation to Sublingual Buprenorphine, and the Avoidance of Precipitated Withdrawal: A Review of the Literature and Demonstration in Three Chronic Pain Patients Treated With Butrans.

Am J Ther. 2013 Jul 10;
Kornfeld H, Reetz H

Buprenorphine… Continue reading

Obesity Alters the Gustatory Perception of Lipids in the Mouse: Plausible Involvement of the Lingual CD36.

Obesity alters the gustatory perception of lipids in the mouse: plausible involvement of the lingual CD36.

J Lipid Res. 2013 Jul 9;
Chevrot M, Bernard A, Ancel D, Buttet M, Martin C, Abdoul-Azize S, Merlin JF, Poirier H, Niot… Continue reading

Integrating the Human Sciences to Evolve Effective Policies.

Integrating the Human Sciences to Evolve Effective Policies.

J Econ Behav Organ. 2013 Jun 1; 90(Suppl): S152-S162
Biglan A, Cody C

This paper describes an evolutionary perspective on human development and wellbeing and contrasts it with the model of… Continue reading

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone.

Open label trial of naltrexone implants: measuring blood serum levels of naltrexone.

Subst Abuse. 2013; 7: 75-84
Colquhoun RM

The usefulness of oral naltrexone has been limited by compliance. Sub-cutaneous implants would seem to offer a solution to this… Continue reading

?CaMKII Autophosphorylation Controls the Establishment of Alcohol-Induced Conditioned Place Preference in Mice.

?CaMKII autophosphorylation controls the establishment of alcohol-induced conditioned place preference in mice.

Behav Brain Res. 2013 May 31;
Easton AC, Lucchesi W, Mizuno K, Fernandes C, Schumann G, Giese KP, Müller CP

The autophosphorylation of alpha Ca(2+)/calmodulin dependent protein… Continue reading

MicroRNAs and Drug Addiction.

MicroRNAs and Drug Addiction.

Front Genet. 2013; 4: 43
Bali P, Kenny PJ

Drug addiction is considered a disorder of neuroplasticity in brain reward and cognition systems resulting from aberrant activation of gene expression programs in response to prolonged… Continue reading

Deleuze and the Theory of Addiction.

Deleuze and the theory of addiction.

J Psychoactive Drugs. 2013 Jan-Mar; 45(1): 57-67
Oksanen A

This theoretical article presents and applies the theories of the French philosopher Gilles Deleuze. The article takes as its starting point the observation that… Continue reading

GET73 Increases Rat Extracellular Hippocampal CA1 GABA Levels Through a Possible Involvement of Local mGlu5 Receptor.

GET73 increases rat extracellular hippocampal CA1 GABA levels through a possible involvement of local mGlu5 receptor.

Synapse. 2013 Apr 8;
Beggiato S, O’Connor WT, Tomasini MC, Antonelli T, Loche A, Tanganelli S, Cacciaglia R, Ferraro L

N-[(4-trifluoromethyl) benzyl] 4-methoxybutyramide… Continue reading